Quipt Home Medical Corp. (QIPT)

Quipt Home Medical Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	240.85	245.92	211.68	127.64	94.39	72.64
Revenue Growth (YoY)	-0.20%	16.18%	65.84%	35.22%	29.95%	18.77%
Cost of Revenue	67.26	68.93	57.9	33.21	28.17	19.93
Gross Profit	173.59	176.99	153.78	94.42	66.22	52.71
Selling, General & Admin	122.33	122.54	103.22	65.2	44.66	38.63
Other Operating Expenses	-	-	-	-4.89	-	-0.14
Operating Expenses	174.84	175.58	149.73	88.85	67.39	53.2
Operating Income	-1.25	1.41	4.05	5.57	-1.17	-0.49
Interest Expense	-8.12	-8.29	-5.91	-2.08	-1.99	-1.84
Interest & Investment Income	0.73	0.79	0.37	-	-	-
Earnings From Equity Investments	-0.28	-0.31	-0.09	-	-	-
Currency Exchange Gain (Loss)	-0.78	0.04	0.11	-0.14	-0.17	0.45
Other Non Operating Income (Expenses)	0.9	-	-	-	-2.11	-0.41
EBT Excluding Unusual Items	-8.81	-6.36	-1.48	3.35	-5.45	-2.29
Merger & Restructuring Charges	-0.29	-0.4	-1.27	-0.8	-0.23	-0.09
Gain (Loss) on Sale of Assets	0.13	0.11	0.08	-0.05	0.09	0.07
Legal Settlements	-	-	-	-	-0.15	-
Other Unusual Items	-	-	-0.03	0.43	-3.59	-1.27
Pretax Income	-8.97	-6.65	-2.7	2.94	-9.33	-3.58
Income Tax Expense	-0.31	0.11	0.09	-1.9	-3.16	0.13
Earnings From Continuing Operations	-8.66	-6.76	-2.78	4.84	-6.17	-3.7
Earnings From Discontinued Operations	-	-	-	-	-	-0.87
Net Income	-8.66	-6.76	-2.78	4.84	-6.17	-4.57
Net Income to Common	-8.66	-6.76	-2.78	4.84	-6.17	-4.57
Shares Outstanding (Basic)	43	43	39	34	30	23
Shares Outstanding (Diluted)	43	43	39	36	30	23
Shares Change (YoY)	3.30%	10.09%	6.35%	19.27%	33.96%	9.68%
EPS (Basic)	-0.20	-0.16	-0.07	0.14	-0.20	-0.20
EPS (Diluted)	-0.21	-0.16	-0.07	0.13	-0.20	-0.20
Free Cash Flow	25.88	25.07	30.13	17.18	12.72	13.94
Free Cash Flow Per Share	0.60	0.59	0.78	0.47	0.42	0.61
Gross Margin	72.07%	71.97%	72.65%	73.98%	70.16%	72.56%
Operating Margin	-0.52%	0.57%	1.91%	4.37%	-1.24%	-0.68%
Profit Margin	-3.60%	-2.75%	-1.31%	3.79%	-6.54%	-6.29%
Free Cash Flow Margin	10.75%	10.19%	14.23%	13.46%	13.47%	19.20%
EBITDA	43.75	45.99	40.15	24.4	13.84	11.88
EBITDA Margin	18.16%	18.70%	18.96%	19.11%	14.66%	16.36%
D&A For EBITDA	45	44.58	36.1	18.83	15.01	12.38
EBIT	-1.25	1.41	4.05	5.57	-1.17	-0.49
EBIT Margin	-0.52%	0.57%	1.91%	4.37%	-1.24%	-0.68%
Revenue as Reported	240.85	245.92	211.68	139.86	102.35	72.64

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q